COX-2 inhibitors: increased risk of CV events?

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2001年 / 867卷 / 1期
关键词：
Celecoxib; Naproxen; Rofecoxib; Nabumetone; Adverse Event Reporting System;
D O I：
10.2165/00128415-200108670-00001
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2 / 2
相关论文
共 50 条
  • [31] COX-2-dependent and independent effects of COX-2 inhibitors and NSAIDs on proatherogenic changes in human monocytes/macrophages
    Voloshyna, Iryna
    Kasselman, Lora J.
    Carsons, Steven E.
    Littlefield, Michael J.
    Gomolin, Irving H.
    De Leon, Joshua
    Reiss, Allison B.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2017, 65 (03) : 694 - 704
  • [32] COX-2 inhibitors: lower risk of pancreatitis than other NSAIDs
    Reactions Weekly, 2006, 1116 (1) : 4 - 4
  • [33] Temporal Relationship between Use of NSAIDs, Including Selective COX-2 Inhibitors, and Cardiovascular Risk
    Stephen P. Motsko
    Karen L. Rascati
    Anthony J. Busti
    James P. Wilson
    Jamie C. Barner
    Kenneth A. Lawson
    Jason Worchel
    Drug Safety, 2006, 29 : 621 - 632
  • [34] Reduced Risk of Bone Metastasis for Patients With Breast Cancer Who Use COX-2 Inhibitors
    Valsecchi, Matias E.
    Pomerantz, Sherry C.
    Jaslow, Rebecca
    Tester, William
    CLINICAL BREAST CANCER, 2009, 9 (04) : 225 - 230
  • [35] New studies confirm GI safety of COX-2 inhibitors
    Reactions Weekly, 2002, 921 (1) : 5 - 5
  • [36] The brand new selective COX-2 inhibitors NSAIDs.
    Cano, DL
    Rodríguez, BG
    Domínguez, YT
    Delgado, PH
    Esteban, JMH
    Gutiérrez, JMH
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 1999, 91 (08) : 598 - 598
  • [37] COX-2 specific inhibitors in NSAID-intolerant patients
    Picado, C
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2003, 16 (02): : 11 - 16
  • [38] Carbonic anhydrase/COX-2 inhibitors in the treatment of various diseases
    不详
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2004, 14 (12) : 1803 - 1806
  • [39] COX-2 Inhibitors for the Prevention of Heterotopic Ossification After THA
    Vasileiadis, George I.
    Sioutis, Ioannis C.
    Mavrogenis, Andreas F.
    Vlasis, Konstantinos
    Babis, George C.
    Papagelopoulos, Panayiotis J.
    ORTHOPEDICS, 2011, 34 (06) : 467 - 472
  • [40] COX-2 inhibitors differ in their potential to cause ischaemic stroke
    Reactions Weekly, 2006, 1117 (1) : 5 - 5
12345